'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.' IMAGE: COVID-19 vaccination in Jaipur,......
'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,' said a senior executive......
So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports. IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......
While Bharat Biotech’s Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been......
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......
The government hopes that the PLI schemes would provide 200,000-300,000 direct employment over five years, according to sources in the know. In a move that has lifted the industry sentiment in the......
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation. Even as the......
Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal......